Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Soligenix, Inc.
3156
Soligenix, Inc.
Technology
Biotechnology
Developing life-saving products and #vaccines for inflammatory diseases and #biodefense. $SNGX
Suggest edits
Type
B2b
Raised
$17M
Follow us
Companies in the same industry
Lycia Therapeutics, Inc
Simcha Therapeutics
Imvax
Thrive Earlier Detection
Triumvira Immunologics
Attralus
Zai Lab
ReGelTec
Aro Biotherapeutics
Ossium Health
Alexa global traffic share
Twitter followers
Overview
Funding
4
Add info
Add round
18 Sep
2017
$1,500,000
Grant
National Cancer Institute (NCI)
14 Aug
2017
$2,500,000
Post-IPO equity
Soligenix Receives $2.5M in Additional NIAID Funding to Advance Development of Heat Stable Ricin Vaccine
prnewswire
26 Jun
2013
$7,100,000
Post-IPO equity
02 Jul
2010
$5,904,277
Venture capital
